Deceased donor organ transplantation restores organ function in patients facing end-stage organ failure. By procuring viable organs from individuals declared deceased under neurological or circulatory criteria, transplant surgical teams re-establish physiological perfusion and organ function. Programs follow strict organ allocation protocols regulated by national governing bodies like the Organ Procurement and Transplantation Network (OPTN) to ensure equitable, evidence-based distribution.

Deceased donor organ transplantation involves four major operational phases: donor identification and organ preservation, recipient preoperative preparation, surgical implantation, and post-transplant ICU stabilization. The surgical phase begins with an incision tailored to the organ (e.g., abdominal midline or subcostal for liver, lower quadrant for kidney, median sternotomy for heart/lung). Vascular anastomoses connect donor and recipient blood vessels using non-absorbable sutures. Tissue ischemia time is kept to a strict minimum to reduce graft dysfunction. After revascularization and organ reperfusion, structural reconstruction (such as ureteral re-implantation or biliary anastomosis) is performed. Hemostasis is verified, drains are positioned, and surgical incisions are closed in layers.

Evidence shows that deceased donor organ transplantation significantly prolongs life expectancy compared to supportive care or mechanical organ replacement therapies. According to data from the Organ Procurement and Transplantation Network (OPTN 2022 Report), successful transplantation restores organ-specific physiology, reduces long-term mortality, resolves metabolic disturbances, and markedly improves patient health-related quality of life.

Immediate hospital recovery lasts between 7 and 14 days for stable single-organ recipients, including 1 to 3 days in the intensive care unit. Initial surgical healing occurs within 6 to 8 weeks. Full functional recovery, drug dosing optimization, and return to standard daily activities generally develop over 3 to 6 months. Patients require lifelong clinical surveillance and strict adherence to daily immunosuppressive drug regimens.

Deceased donor organ transplantation treats terminal organ dysfunction. Primary indications include end-stage renal disease (ESRD), decompensated cirrhosis, end-stage heart failure, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis, type 1 diabetes mellitus with severe vascular complications, and irreversible intestinal failure.

Candidate evaluation requires blood typing (ABO compatibility), tissue typing (human leukocyte antigen matching), crossmatching to detect pre-formed anti-donor antibodies, cardiopulmonary fitness testing, baseline infectious disease screening, and psychosocial assessment. Patients on the waiting list must remain reachable 24 hours a day, maintain stable health status, and report acute infections immediately. Upon donor matching notice, the patient undergoes immediate fast-state admission, repeated crossmatching, baseline blood draws, chest imaging, and preoperative prophylactic antimicrobial administration.

Complications are categorized by severity and onset timing. Surgical risks include primary graft non-function, vascular thrombosis, anastomotic leaks, surgical site infection, and post-operative bleeding. Immunological risks include hyperacute, acute cellular, or antibody-mediated rejection. Long-term risks associated with required immunosuppression include opportunistic infections (e.g., cytomegalovirus, fungal infections), nephrotoxicity, metabolic disturbances (new-onset diabetes after transplantation), and secondary malignancies such as post-transplant lymphoproliferative disorder (PTLD).

The patient journey begins with a multi-disciplinary evaluation to determine organ failure severity and candidate readiness. Qualified candidates are placed on a national waiting list, managed by allocation algorithms. When a compatible donor organ becomes available, the patient undergoes emergency admission, preoperative preparation, and organ transplantation surgery. Postoperative care includes intensive care monitoring, protocol-driven immunosuppression (medications that prevent organ rejection), graft monitoring, and long-term outpatient surveillance.